Smarter, Faster, Safer Clinical Trials
With Agentic AI.
Empower
From protocol design to FDA submission, Hill Research transforms clinical data workflows with multi-agent AI and automation, cutting cycle times, reducing costs, and ensuring compliance at every step.
Trusted by 10+ global pharma, including 2 of the top 3 and 5 of the top 10
Overcome your obstacles
100% CDISC-ready outputs
fully inspection-ready deliverables
99%+ validation accuracy
AI-assisted quality assurance
70% faster TLF generation
accelerate statistical programming
Up to 100× faster annotation
automate CRF/CDISC mapping
Our One Stop Statistical Programming Platform
TriClick™
Compliance
Automated validation, anonymization, and audit trails for global regulatory readiness.
TriClick™
Annotation
AI-driven annotation with unmatched speed and consistency.
TriClick™
Evidence
Extract and synthesize multi-source evidence to support clinical and regulatory decisions.
TriClick™
Stats
Automatically generate TLFs from SAP, ensuring accuracy and traceability.
To make every trial faster, safer, and smarter with the power of agentic AI.
Our Services
SAS Programming with GenAI
End-to-end automation and validation of CDISC datasets, TLFs, and e-submissions.
Functional Service Provider (FSP)
Scalable biometrics and programming teams integrated into sponsor workflows, enhanced by AI.
Biostatistics & Clinical Development
Adaptive/Bayesian design, SAP development, IDMC/PK-PD/RWE, and publication support.
More Customized Services
Trusted by Our Client
“Hill Research delivers a truly revolutionary improvement in clinical programming, reducing 60–70% of manual workload and enabling rapid, high-quality statistical outputs with just a few clicks. Their unique blend of AI and clinical expertise is exactly what pharma needs today.”
— Clinical operations professional at a Top 10 global pharmaceutical company
“Hill Research is transforming clinical trials by automating the most time-consuming and error-prone data tasks — enabling faster insights, higher quality results, and ultimately quicker access to life-saving treatments.”
—Bioinformatics & Clinical Data Leaders, Global Pharma